Charlene A. Wong|Mona Saraiya|Susan Hariri|Linda O. Eckert|Roberta I. Howlett|Lauri E. Markowitz|Julia Brotherton|Katy Sinka|Olga Georgina Martínez-Montañez|Susanne K. Kjær|Eileen F. Dunne
Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries
Centers for Disease Control and Prevention|Centers for Disease Control and Prevention|Centers for Disease Control and Prevention|University of Washington|Public Health Ontario|University of Toronto|Centers for Disease Control and Prevention|Health Protection Scotland|University of Copenhagen|Rigshospitalet|Centers for Disease Control and Prevention
review describe plans monitor impact human papillomavirus hpv vaccine biologic outcomes selected international areas australia canada mexico nordic countries scotland united states adopted vaccine summary monitoring plans provides background discussing challenges vaccine monitoring settings resources capacity may vary variety approaches depend existing infrastructure resources planned underway monitoring hpv vaccine impact monitoring hpv vaccine impact biologic outcomes complex challenging task also plays important role documenting benefit vaccination monitoring progress vaccination programs providing data inform vaccination disease prevention policies